Tanezumab: a selective humanized mAb for chronic lower back pain

Chronic lower back pain is a significant disease that affects nearly 20% of the worldwide population. Along with hindering patients’ quality of life, chronic lower back pain is considered to be the second most common cause of disability among Americans. Treating chronic lower back pain is often a ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Webb, Michael P, Helander, Erik M, Menard, Bethany L, Urman, Richard D, Kaye, Alan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825994/
https://www.ncbi.nlm.nih.gov/pubmed/29503555
http://dx.doi.org/10.2147/TCRM.S144125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825994/
https://www.ncbi.nlm.nih.gov/pubmed/29503555
http://dx.doi.org/10.2147/TCRM.S144125

Ejemplares similares